Affiliation:
1. School of Basic Medicine Sciences, Weifang Medical University, Weifang, Shandong, 261053, P.R. China
Abstract
:
Cardiovascular Disease (CVD) is the leading cause of morbidity and death worldwide
and has become a global public health problem. Traditional Chinese medicine (TCM) has been
used in China to treat CVD and achieved promising results. Therefore, TCM has aroused significant
interest among pharmacologists and medical practitioners. Previous research showed that
TCM can regulate the occurrence and development of atherosclerosis (AS), ischemic heart disease,
heart failure, myocardial injury, and myocardial fibrosis by inhibiting vascular endothelial
injury, inflammation, oxidant stress, ischemia-reperfusion injury, and myocardial remodeling. It
is well-known that TCM has the characteristics of multi-component, multi-pathway, and multitarget.
Here, we systematically review the bioactive components, pharmacological effects, and
clinical application of TCM in preventing and treating CVD.
Publisher
Bentham Science Publishers Ltd.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献